Daniel M Junius insider trades: Idexx Laboratories (IDXX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | IDXX | ↓ Sell | 1,200 | $704.07 | $845K | Direct | Nov 5, 2026 (1d) |
| May 13, 2025 | IDXX | ↓ Sell | 2,683 | $506.41 | $1.4M | Direct | May 14, 2025 (1d) |
| May 10, 2023 | GLYC | ↑ Buy | 30,000 | $1.56 | $47K | Direct | May 11, 2023 (1d) |
| Feb 16, 2023 | IDXX | ↓ Sell | 2,187 | $511.68 | $1.1M | Direct | Feb 17, 2023 (1d) |
| Dec 5, 2022 | IDXX | ↓ Sell | 3,046 | $424.91 | $1.3M | Direct | Dec 7, 2022 (2d) |
| Nov 17, 2022 | GLYC | ↑ Buy | 20,000 | $1.87 | $37K | Direct | Nov 18, 2022 (1d) |
| Aug 10, 2021 | IDXX | ↓ Sell | 2,402 | $679.58 | $1.6M | Direct | Aug 12, 2021 (2d) |
| May 21, 2021 | IDXX | ↓ Sell | 2,500 | $539.57 | $1.3M | Direct | May 24, 2021 (3d) |
| Feb 22, 2021 | IDXX | ↓ Sell | 1,898 | $538.57 | $1.0M | Direct | Feb 24, 2021 (2d) |
| Aug 20, 2020 | IDXX | ↓ Sell | 3,722 | $382.61 | $1.4M | Direct | Aug 21, 2020 (1d) |
| May 19, 2020 | IDXX | ↓ Sell | 4,000 | $295.61 | $1.2M | Direct | May 20, 2020 (1d) |
| Mar 9, 2020 | GLYC | ↑ Buy | 20,000 | $3.40 | $68K | Direct | Mar 10, 2020 (1d) |
| Aug 13, 2019 | GLYC | ↑ Buy | 10,000 | $3.18 | $32K | Direct | Aug 15, 2019 (2d) |
| Mar 16, 2018 | IMGN | ↓ Sell | 25,000 | $12.02 | $300K | Direct | Mar 16, 2018 (0d) |
| Feb 28, 2018 | IDXX | ↓ Sell | 2,974 | $190.06 | $565K | Direct | Mar 2, 2018 (2d) |
| Feb 21, 2018 | IMGN | ↓ Sell | 11,713 | $12.00 | $141K | Direct | Feb 23, 2018 (2d) |
| Feb 20, 2018 | IMGN | ↓ Sell | 25,000 | $11.68 | $292K | Direct | Feb 21, 2018 (1d) |
| Feb 13, 2018 | IMGN | ↓ Sell | 46,667 | $10.01 | $467K | Direct | Feb 14, 2018 (1d) |
| Feb 8, 2017 | IDXX | ↓ Sell | 3,000 | $141.75 | $425K | Direct | Feb 9, 2017 (1d) |
| Dec 20, 2016 | GLYC | ↑ Buy | 5,000 | $6.01 | $30K | Direct | Dec 21, 2016 (1d) |
| Jan 4, 2016 | IMGN | ↓ Sell | 5,416 | $13.17 | $71K | Direct | Jan 4, 2016 (0d) |
| Dec 1, 2015 | IMGN | ↓ Sell | 5,416 | $13.11 | $71K | Direct | Dec 1, 2015 (0d) |
| Nov 2, 2015 | IMGN | ↓ Sell | 5,497 | $12.00 | $66K | Direct | Nov 3, 2015 (1d) |
| Oct 29, 2015 | IMGN | ↓ Sell | 5,335 | $12.01 | $64K | Direct | Oct 30, 2015 (1d) |
| Sep 1, 2015 | IMGN | ↓ Sell | 5,416 | $13.15 | $71K | Direct | Sep 1, 2015 (0d) |
| Aug 3, 2015 | IDXX | ↑ Buy | 1,000 | $73.15 | $73K | Direct | Aug 5, 2015 (2d) |
| Aug 3, 2015 | IMGN | ↓ Sell | 5,416 | $17.03 | $92K | Direct | Aug 4, 2015 (1d) |
| Jul 1, 2015 | IMGN | ↓ Sell | 5,416 | $14.34 | $78K | Direct | Jul 2, 2015 (1d) |
| May 7, 2015 | IMGN | ↓ Sell | 1,215 | $8.02 | $10K | Direct | May 11, 2015 (4d) |
| May 1, 2015 | IMGN | ↓ Sell | 35,315 | $8.36 | $295K | Direct | May 5, 2015 (4d) |
| Mar 17, 2014 | IMGN | ↓ Sell | 15,000 | $16.40 | $246K | Direct | Mar 18, 2014 (1d) |
| Feb 18, 2014 | IMGN | ↓ Sell | 15,000 | $16.26 | $244K | Direct | Feb 20, 2014 (2d) |
| Dec 10, 2013 | IMGN | ↓ Sell | 15,000 | $15.11 | $227K | Direct | Dec 12, 2013 (2d) |
| Sep 3, 2013 | IMGN | ↓ Sell | 16,667 | $16.43 | $274K | Direct | Sep 5, 2013 (2d) |
| Aug 1, 2013 | IMGN | ↓ Sell | 16,667 | $19.21 | $320K | Direct | Aug 2, 2013 (1d) |
| Jul 3, 2013 | IMGN | ↓ Sell | 16,667 | $17.31 | $289K | Direct | Jul 5, 2013 (2d) |
| Aug 21, 2007 | IMGN | ↑ Buy | 10,000 | $4.47 | $45K | Direct | Aug 23, 2007 (2d) |
| Aug 20, 2007 | IMGN | ↑ Buy | 20,000 | $4.45 | $89K | Direct | Aug 21, 2007 (1d) |
| Aug 16, 2007 | IMGN | ↑ Buy | 10,000 | $4.34 | $43K | Direct | Aug 17, 2007 (1d) |
| Aug 15, 2007 | IMGN | ↑ Buy | 10,000 | $4.47 | $45K | Direct | Aug 16, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IDXX insiders
Open-market trades in the last 12 months
About Daniel M Junius's insider trades
Daniel M Junius is a director at Idexx Laboratories (IDXX). Since Aug 15, 2007, Daniel has reported 10 open-market purchases worth $509K and 30 sales worth $15.8M on SEC Form 4. In the last 12 months: 1 sale ($845K).
Their filings also include grants and awards (76 filings), option exercises (39 filings), shares returned to the company (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDXX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.